Home | BSAAM's Organizer | BSAAM's Sponsor | Contact Us
BSAAM's Anti Ageing Conference London 2019
Follow us on ...
Facebook  Twitter  Instagram
Conference Information
Register Info
Delegate Information
A4M Board Certification
  American Board Of Anti-Aging/Regenerative Medicine (ABAARM)
Past Conference Information
2018 Speakers and Presentations
2018 Programme
2018 Exhibitors

BSAAMs AACL 2018 Peer Review Board Members
2017 Speakers and Presentations
2017 Programme
2017 Exhibitors

BSAAMs AACL 2017 Peer Review Board Members
2016 Speakers and Presentations
2016 Programme
2016 Exhibitors
2016 Moderators
BSAAMs AACL 2016 Peer Review Board Members
2015 Speakers and Presentations
2015 Programme
2015 Exhibitors
2015 Moderators
BSAAMs AACL 2015 Peer Review Board Members
2014 Speakers and Presentations
2014 Programme
2014 Exhibitors
2014 Moderators
2014 Peer Review Board Members
2014 Aesthetic Peer Review Board Members
2013 Speakers and Presentations
2013 Programme
2013 Exhibitors
2013 Moderators
2013 Peer Review Board Members
2013 Aesthetic Peer Review Board Members
2012 Speakers and Presentations
2012 Programme
2012 Exhibitors
2012 Moderators
2012 Peer Review Board Members
2012 Aesthetic Peer Review Board Members
2011 Speakers and Presentations
2011 Programme
2011 Exhibitors
2011 Moderators
2011 Peer Review Board Members
2011 Aesthetic Peer Review Board Members
2010 Conference Manual
2010 Speakers and Presentations
2010 Programme
2010 Exhibitors
2010 Moderators
2010 Peer Review Board Members
2010 Aesthetic Peer Review Board Members
Programme for the 2009
Exhibitors for the 2009
Speakers for the 2009
2009 Peer Review Board Members
2009 Aesthetic Peer Review Board Members
Programme for 2008
Exhibitors for 2008
Speakers for 2008
2008 Peer Review Board Members
2008 Aesthetic Peer Review Board Members
  2007 Speaker List
2007 Speaker Programme
  Pre Conference Workshops
Sept 12 Pre-Conference Workshop Programme
Sept 13 Pre-Conference Workshop Programme
  2007 Peer Review Board Members
  Exhibitors for 2007
  3rd Annual Anti-Ageing Conference Manual (2006)
  Programme for 2006
  ISRM2006 Scientific Board Members
  2006 Peer Review Board Members
  Exhibitors 2006
  Post Review of 2005
  Remarks about 2005
  Peer Review Board of 2005
  Past Speakers 2005
  Past Speakers 2004
  Past Speakers Monte Carlo 2002
BSAAM's AACL Organizer
BSAAM Affiliates
AACL Supporters
HB Health
  Sun Chlorella

AACL 2010 Speaker

Dr Walter PierpoliDr Walter Pierpaoli MD PhD
Born in Milano, graduates in Medicine at the University  of Milano in 1960.
Works as assistant and researcher at the Institute of General Pathology and obtains a PhD in Immunology. From 1963 until 1969 occupies the position of Laboratory Director at the Center of Cellular Pathology of the Italian National Research Council in Milano. Moves to Switzerland in 1969 as Head of Neuroimmunology Laboratory at the Swiss Institute of Medical Research in Davos-Platz, where he stays  until 1977.
Director of the NeuroImmuno Modulation (NIM) Laboratory at the University of Zurich until  1980. In 1980 he establishes his own Research Laboratory and Institute for Integrative Biomedical Research  and the INTERBION Foundation for Basic Biomedical Research in Zurich. In 1988 the Institute and the Foundation are moved to Ticino, South Switzerland,. He is now Director of the "Jean Choay Institute for Neuroimmunomodulation" in Riva San Vitale, Switzerland. His scientific and clinical activity estends from basic research to clinical studies of new anti-aging interventions and therapies, and a totally new transplantation method based on a  discovery and granted patents. He is author of over 130 publications on refereed scientific journals and organizer of the "Stromboli Conferences on Aging and Cancer" in 1987, 1990, 1993 and 2005. He has also published popular books such as the "Melatonin Miracle", translated into 15 languages and a New York Times bestseller (1995).

Aging-Reversing Properties of Thyrotropin Releasing Hormone (TRH)

Work in our laboratory has shown the remarkable and varied  effects of TRH
in the rapid reversal of aging-related changes and alterations in old rodents. It was also demonstrated that these restoring effects of TRH were not exerted via the thyroid gland,  with the obvious increase of synthesis or secretion of thyroid  hormones, but depended on a newly found and rather unexpected direct activity of TRH.  We suggested that the tripeptide TRH,  thanks to its ubiquitous localization in nature and its high concentration in key tissues such as the  pineal gland, the pancreatic insulin-producing beta cells and the anterior hypothalamic area, represents a vehicle for most fundamental energy-regulating and hormone-synchronizing  activities.
In fact, the restoring effects of TRH could be seen  in all models used, such as  aging, immunodeficient animals, virus-infected and stressed mice, hypothalamus lesioned mice and in particular in old animals with typical  adiposity and  progressive decay of neuroendocrine, immune and hormonal  functions. TRH  associated to melatonin normalizes lipid metabolism and  prolongs longevity in aging mice.  All this previous work prompted us to study the effects of short-term, acute administration of TRH or its chronic  oral administration,  on organs, tissues and aging-related metabolic and hormonal markers,  in order to acquire more knowledge on effects, dosage and timing of administration according to its circadian cyclicity.  In addition, we wanted to verify its anti-aging effects on two most fundamental functions, namely gonadal- reproductive  and  kidney-urinary.
The results  demonstrate that  both a short-term, acute or a chronic, long-term oral  administration of  TRH to old, aging mice, results into  positive changes and rapid correction to more juvenile levels of most typical aging-related hormonal and metabolic alterations.
Remarkably, 4-month oral  treatment with TRH maintains testes function in aging mice. As hinted by the significant increase of testes weight,  TRH taken from the drinking water produces a maintenance and/or reconstitution of  testes structure and function as shown by active proliferation and formation of mature spermatogonia and intensive  spermatogenesis in the follicles. Apparently TRH greatly enhances the final maturation process of  spermatogonia to spermatozoa.
4-month oral treatment with TRH  protects the kidneys from amylod and hyalin infiltration of  both tubuli and glomeruli, which is typical of aging mice. In fact, massive deposits of amyloid and hyalin material are clearly  infiltrating the shrunken glomeruli of untreated mice with loss of filtration capacity, while hardly present in TRH-treated mice.  Massive hyalin degeneration can also be observed in the  tubular vessels of the untreated control mice.
The extensive and repeated experiments with parenteral and oral administration of TRH show a most remarkable aging-delaying and  apparently even aging-reversing  effects of  the neuropeptide TRH.  Again, similarly to melatonin, we are confronted  with  an anti-aging agent with a broad spectrum of activities which must be necessarily linked to a most fundamental role in the regulation of  metabolic and hormonal functions.
Pierpaoli, W. and Yi, C.X. The involvement of pineal gland and melatonin in immunity and aging. I. Thymus-mediated, immunoreconstituting and antiviral activity of thyrotropin releasing hormone (TRH). J. Neuroimmunol. 27: 99-109, 1990.                                                                                  Pierpaoli, W., Bulian D., Bulian G., and Kistler, G. Thyrotropin releasing hormone (THR) accelerates and enhances the aging-postponing effects of melatonin. J. Anti-Aging Med 2: 343-348,1999.

View .pdf of Presentation here!

Home | BSAAM's Organizer | BSAAM's Sponsor | Contact Us
BSAAM's Anti Ageing Conference London, 38 Regent on the River
William Morris Way London SW6 2UT, United Kingdom
Tel: +44 (0)79 7317 3478  Fax: +44 (0)20 7491 0410
Emails :